» Mesothelioma Chemotherapy

» Mesothelioma Survivor

» Mesothelioma Treatment Options

» Mesothelioma Risk

» Mesothelioma Survival Rate

» Mesothelioma Cancer

» Mesothelioma Facts

» Mesothelioma Resource

» Mesothelioma Lung

» Mesothelioma Compensation

» Mesothelioma Incidence

» Malignant Mesothelioma

» Benign Mesothelioma

» Pleural Mesothelioma

» Pericardial Mesothelioma

» Malignant Pleural Mesothelioma

» Mesothelioma Stage

» Mesothelioma Smoking

» Abdominal Mesothelioma

Mesothelioma Applied Research Foundation

     
The Mesothelioma Applied Research Foundation (MARF) is an American national nonprofit organization committed to eradicating mesothelioma as a life-ending disease.

• funding the highest quality and most promising research projects from around the world through our rigorous peer-reviewed process

• helping patients obtain information on their treatment options which is completely up-to-date and unbiased

• and advocating in Washington D.C. for federal Mesothelioma research funding to stop this national tragedy.

The work of the Foundation is funded by meso patients and their families who have invested generously in the search for a cure, as well as law firms, drug companies, and companies formerly involved with asbestos, all of whom have attached in the general mission of curing the disease.

The Mesothelioma Applied Research Foundation (MARF) was formed in late 1999 to restore hope and end the misery for mesothelioma patients and their families. Their mission is to eradicate mesothelioma as a life-ending disease through research, education and awareness.

The Minnesota Department of Health is launching two major studies to answer long-simmering questions about taconite and human health. The organization says men in northeastern Minnesota have double the expected rate of a rare form of cancer called mesothelioma. The first to persuade Congress to appropriate funds for meso research; the first to organize an annual meso symposium to bring together patients, doctors, researchers and advocates; and the first to address the requirements of patients and families for hope and medical information through a robust patient education program.

There is thrilling news for patients with mesothelioma in the making. Two pharmaceutical companies have started a clinical phase II clinical trial to test the efficacy and movement of a new drug in mesothelioma. I am grateful to succeed Roger's visionary leadership, and to continue to raise what he started. The Meso Foundation is fortunate to have committed staff, amazing volunteers and a growing body of public leaders, researchers, patients, and families who turn to us as the definitive association for meso information, support of research, and advocacy. Together in the coming years we will raise our impact on overcoming the meso tragedy.

We invite you to participate in our new gathering. We are looking for quality news items that would be attractive to our readers. Inclusion of news item at our site get instantaneous attention since the item is illustrated from various blog posts.Now you may propose the news item from your site to be included at Medicineworld.org. Addition of pictures to the item adds additional attraction to your news item.

» Epithelioid Mesothelioma

» International Mesothelioma

» Mesothelioma Scholarship

» Mesothelioma Memorial

» Mesothelioma Claims

» Mesothelioma Applied
   Research Foundation

» Diagnosed With Mesothelioma

» Mesothelioma Death

» Asbestos Mesothelioma

» Mesothelioma Doctor

» Asbestos Cancer    Mesothelioma

» Mesothelioma Article

» Mesothelioma Prognosis

» Accident Attorney Michigan

» Mesothelioma Diagnosis

» Mesothelioma Statistics
© 2008 All rights reserved